Drugs / amoxicillin/clavulanate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00051753 | Nov 2002 → May 2005 | otitis media | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | amoxicillin/clavulanate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00051753 ↗ |
| Route | Oral | “Both study drugs will be given orally as a liquid suspension formulation” NCT00051753 ↗ |